ATE318142T1 - Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern - Google Patents

Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern

Info

Publication number
ATE318142T1
ATE318142T1 AT98944936T AT98944936T ATE318142T1 AT E318142 T1 ATE318142 T1 AT E318142T1 AT 98944936 T AT98944936 T AT 98944936T AT 98944936 T AT98944936 T AT 98944936T AT E318142 T1 ATE318142 T1 AT E318142T1
Authority
AT
Austria
Prior art keywords
channel blockers
steady
state
calcium
specific
Prior art date
Application number
AT98944936T
Other languages
English (en)
Inventor
Ghassan Bkaily
Orleans-Juste Pedro D
Joao B Calixto
Rosendo A Yunes
Original Assignee
Univ Sherbrooke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sherbrooke filed Critical Univ Sherbrooke
Application granted granted Critical
Publication of ATE318142T1 publication Critical patent/ATE318142T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98944936T 1997-09-30 1998-09-28 Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern ATE318142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002217088A CA2217088A1 (en) 1997-09-30 1997-09-30 New mandevilla velutina derivatives as steady-state r-type ca2+ channel blockers, method of making and use thereof

Publications (1)

Publication Number Publication Date
ATE318142T1 true ATE318142T1 (de) 2006-03-15

Family

ID=4161555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944936T ATE318142T1 (de) 1997-09-30 1998-09-28 Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern

Country Status (7)

Country Link
EP (1) EP1028734B1 (de)
AT (1) ATE318142T1 (de)
AU (1) AU9248998A (de)
BR (1) BR9812579A (de)
CA (1) CA2217088A1 (de)
DE (1) DE69833557T2 (de)
WO (1) WO1999016449A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
MXPA02007248A (es) * 2000-01-28 2002-12-09 Procter & Gamble Compuestos de arginina con sabor aceptable y usos de los mismos para la salud cardiovascular.
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0359310A1 (de) * 1988-09-15 1990-03-21 The Procter & Gamble Company Mandevilla-pentlandiana-Extrakte als Bradykininantagonist

Also Published As

Publication number Publication date
BR9812579A (pt) 2000-07-25
EP1028734B1 (de) 2006-02-22
EP1028734A1 (de) 2000-08-23
CA2217088A1 (en) 1999-03-30
DE69833557T2 (de) 2006-10-05
AU9248998A (en) 1999-04-23
WO1999016449A1 (en) 1999-04-08
DE69833557D1 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
DE69817446D1 (de) Behandlung von diabetes
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE69534360D1 (de) Zentrale Quelle von mehreren Wellenlängen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE291897T1 (de) Verwendung von zusammensetzungen mit stabilisierten enzymen
ATE260332T1 (de) Behandlung von textilien
DE69623472D1 (de) Derivate von dolastatin, dreen herstellung un verwendung
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69716647T2 (de) Biologische behandlung von gebrauchten kaustischen laugen
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
DE69708848T2 (de) Mischung von erdalkalialkylarylsulfonaten, ihre verwendung als schmierölzusatz und herstellungsmethode
DE69907146D1 (de) Direkte oxidation von cycloalkanen
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE122007000051I2 (de) Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE69708416D1 (de) Karbothermische Herstellung von Alkalimetallen
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE318142T1 (de) Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern
DE69926485D1 (de) Behandlung von durchblasgasen
TR199700547A2 (xx) N-asetonilbenzamid fungisitler.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE69918541D1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons
DE59706407D1 (de) Verwendung von polyether-pur für sicherheitskleidung
DE59802138D1 (de) Verwendung von wachs
DE69917445D1 (de) Reinigung von carboxaldehyd

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties